SCHEMBL7474876

SCHEMBL7474876

CCCc1[nH]c2ccccc2c1C(=O)OC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 3/20 0.61
ALOX5 P09917 5/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
ATM Q13315 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
ALDH1A1 P00352 2/20 0.52
KDM4E B2RXH2 2/20 0.52
HPGD P15428 1/20 0.52
HSD17B10 Q99714 1/20 0.52
CHRNB2 P17787 1/20 0.50
CHRNA7 P36544 1/20 0.50
CHRNA4 P43681 1/20 0.50
OXER1 Q8TDS5 1/20 0.50
GABRP O00591 1/20 0.48
GABRD O14764 1/20 0.48
GABRA1 P14867 1/20 0.48
GABRB1 P18505 1/20 0.48
GABRG2 P18507 1/20 0.48
GABRB3 P28472 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15175477 0.88 NR4A2 (0.65) NR4A2ALOX5MEN1KMT2AALDH1A1
SCHEMBL22275928 0.85 NR4A2 (0.65) NR4A2ALOX5MEN1KMT2AALDH1A1
SCHEMBL9353789 0.85 NR4A2 (0.57) NR4A2ALOX5MEN1KMT2AALDH1A1
SCHEMBL7461349 0.85 NR4A2 (0.57) NR4A2ALOX5MEN1KMT2AALDH1A1
SCHEMBL6185644 0.84 NR4A2 (0.63) NR4A2ALOX5MEN1KMT2AALDH1A1
SCHEMBL14638989 0.84 NR4A2 (0.63) NR4A2ALOX5MEN1KMT2AALDH1A1
SCHEMBL14555859 0.83 OXER1 (0.53) NR4A2MEN1KMT2AALDH1A1KDM4E
SCHEMBL7551694 0.83 OXER1 (0.60) KMT2AALDH1A1KDM4EHPGDCHRNB2
SCHEMBL9353800 0.82 NR4A2 (0.55) NR4A2ALOX5MEN1KMT2AALDH1A1
SCHEMBL9358044 0.81 NR4A2 (0.60) NR4A2ALOX5MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1095039-A2 NEW PHARMACEUTICALLY ACTIVE COMPOUNDS AstraZeneca AB (SE) 2001-05-02 EP disclosed
WO-2000002877-A2 NEW PHARMACEUTICALLY ACTIVE COMPOUNDS ASTRAZENECA AB (SE) 2000-01-20 WO disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed